Accessibility statement for the MAMA study app
This accessibility statement applies to the MAMA study mobile app. The app was developed by the Oxford Research Software Engineering Group at the University of Oxford (https://www.rse.ox.ac.uk) for the MAMA study, a randomised controlled trial co-ordinated by the National Perinatal Epidemiology Unit Clinical Trial Unit (NPEU CTU) at the University of Oxford.
Our commitment to accessibility
We at NPEU CTU are committed to making this app accessible, in accordance with the Public Sector Bodies (Websites and Mobile Applications) (No. 2) Accessibility Regulations 2018.
How accessible this app is
We know some parts of this app are not fully accessible. For example:
- Some images may not have appropriate alternative text
- Some form elements and interactive components may not be fully labelled for screen readers
- There may be inconsistencies in heading structure and page landmarks
We are working to improve these areas as the app continues to be evaluated.
What to do if you cannot access parts of this app
The majority of this app can only be accessed once you have set up an account.
If you need information on this app in a different format (for example, accessible PDF, large print, easy read, audio recording or braille), please contact us:
Email: mama@npeu.ox.ac.uk
We will consider your request and get back to you as soon as possible.
Enforcement procedure
If you are not satisfied with our response, you can contact the Equality Advisory and Support Service (EASS):
https://www.equalityadvisoryservice.com
Technical information about this app's accessibility
The NPEU is committed to making this app accessible, in accordance with the Public Sector Bodies Accessibility Regulations 2018.
This app is partially compliant with the Web Content Accessibility Guidelines version 2.1 AA standard, due to the non-compliances listed above.
Preparation of this accessibility statement
This statement was prepared on 20 July 2026.
This app has not undergone a full formal accessibility audit but has been reviewed internally during development. The statement will be updated following further testing and/or development if applicable.